Immunotherapy of prostate cancer: a review.
Tumors are antigenic and patients can mount an immune response against their tumors. Prostate cancer patients are sensitized to their malignancies and immunotherapeutic efforts have been successful. As with other tumors, it is unlikely that immunotherapy alone will be curative, but will play a role in combination therapy along with surgery, radiation, and chemotherapy. But before its rightful place can be delineated, additional clinical and laboratory studies must be completed.
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003452:Cryosurgery; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D051381:Rats
D001500:BCG Vaccine